Home/Filings/4/0001638599-18-000025
4//SEC Filing

Higuchi John W. 4

Accession 0001638599-18-000025

CIK 0001535955other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 6:15 PM ET

Size

7.3 KB

Accession

0001638599-18-000025

Insider Transaction Report

Form 4
Period: 2017-12-29
Transactions
  • Exercise/Conversion

    Restricted stock units

    2017-12-291,2503,750 total
    Exercise: $0.00From: 2017-12-29Exp: 2027-01-25Common Stock (1.25 underlying)
  • Exercise/Conversion

    Common Stock

    2017-12-29+1,250476,498 total
Footnotes (2)
  • [F1]Represents shares of Lipocine Inc. common stock ("LPCN Common Stock") acquired upon the vesting of restricted stock units (see footnote 2).
  • [F2]Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021.

Issuer

Lipocine Inc.

CIK 0001535955

Entity typeother

Related Parties

1
  • filerCIK 0001579891

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 6:15 PM ET
Size
7.3 KB